These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3116876)

  • 21. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
    Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
    Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum lipids, vitamin B12 and folic acid levels in children receiving long-term valproate therapy.
    Geda G; Caksen H; Içağasioğlu D
    Acta Neurol Belg; 2002 Sep; 102(3):122-6. PubMed ID: 12400250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluctuating and constant valproate administration gives equivalent seizure control in rats with genetic and acquired epilepsy.
    Dedeurwaerdere S; van Raay L; Morris MJ; Reed RC; Hogan RE; O'Brien TJ
    Seizure; 2011 Jan; 20(1):72-9. PubMed ID: 21093310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose sodium valproate in the treatment of idiopathic generalized epilepsies.
    Miró J; Aiguabella M; Veciana M; Juvany R; Santurino M; Leiva E; Salas-Puig J; Falip M
    Acta Neurol Scand; 2014 May; 129(5):e20-3. PubMed ID: 24372179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
    Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A
    Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents.
    Steinborn B; Galas-Zgorzalewicz B
    Folia Neuropathol; 2002; 40(2):97-100. PubMed ID: 12230261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children.
    Çiçek NP; Kamaşak T; Serin M; Okten A; Alver A; Cansu A
    Seizure; 2018 May; 58():90-95. PubMed ID: 29679911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
    Ueshima S; Aiba T; Ishikawa N; Sato T; Kawasaki H; Kurosaki Y; Ohtsuka Y; Sendo T
    J Clin Pharm Ther; 2009 Aug; 34(4):415-22. PubMed ID: 19583674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetic model of valproate and prediction of valproate serum concentrations in children with epilepsy.
    Jiang DC; Wang L
    Acta Pharmacol Sin; 2004 Dec; 25(12):1576-83. PubMed ID: 15569400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproate monotherapy in children.
    Murphy JV
    Am J Med; 1988 Jan; 84(1A):17-22. PubMed ID: 3146220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproate and clonazepam comedication in patients with intractable epilepsy.
    Mireles R; Leppik IE
    Epilepsia; 1985; 26(2):122-6. PubMed ID: 3921350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium valproate monotherapy in childhood epilepsy.
    Dulac O; Steru D; Rey E; Perret A; Arthuis M
    Brain Dev; 1986; 8(1):47-52. PubMed ID: 3085530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and pharmacokinetic observations on sodium valproate - a 5-year follow-up study in 100 children with epilepsy.
    Henriksen O; Johannessen SI
    Acta Neurol Scand; 1982 May; 65(5):504-23. PubMed ID: 6810648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacotherapy of epilepsy--current problems and controversies].
    Schmidt D
    Fortschr Neurol Psychiatr; 1983 Nov; 51(11):363-86. PubMed ID: 6418628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of valproate across the ages. Treatment of epilepsy in children.
    Aldenkamp A; Vigevano F; Arzimanoglou A; Covanis A
    Acta Neurol Scand Suppl; 2006; 184():1-13. PubMed ID: 16776492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical implications of serum protein binding in epileptic children during sodium valproate maintenance therapy.
    Yu HY
    Ther Drug Monit; 1984; 6(4):414-23. PubMed ID: 6440321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group.
    Mattson RH; Cramer JA; Collins JF
    N Engl J Med; 1992 Sep; 327(11):765-71. PubMed ID: 1298221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium valproate in the treatment of resistant epilepsy.
    Hassan MN; Laljee HC; Parsonage MJ
    Acta Neurol Scand; 1976 Sep; 54(3):209-218. PubMed ID: 822682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of phenytoin and valproate in previously untreated adult epileptic patients.
    Turnbull DM; Rawlins MD; Weightman D; Chadwick DW
    J Neurol Neurosurg Psychiatry; 1982 Jan; 45(1):55-9. PubMed ID: 6801213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conventional and controlled release valproate in children with epilepsy: a cross-over study comparing plasma levels and cognitive performances.
    Brouwer OF; Pieters MS; Edelbroek PM; Bakker AM; van Geel AA; Stijnen T; Jennekens-Schinkel A; Lanser JB; Peters AC
    Epilepsy Res; 1992 Dec; 13(3):245-53. PubMed ID: 1493787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.